HSA-MnO2-131I Combined Imaging and Treatment of Anaplastic Thyroid

May 21,2024

Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach

Frontiers Radionuclide 131I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer

T1 Mapping From MPRAGE Acquisitions: Application to the Measurement of the Concentration of Nanoparticles in Tumors for Theranostic Use - Lavielle - 2023 - Journal of Magnetic Resonance Imaging - Wiley Online Library

Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy, Journal of Nanobiotechnology

Diagrammatic illustration of epithelial to mesenchymal transition (EMT)

Genomic Profiling of Aggressive Thyroid Cancer in Association With its Clinicopathological Characteristics

Blood–Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy

Primary squamous cell carcinoma of the thyroid treated with concurrent chemoradiation and palliative immunotherapy: a case report, Journal of Medical Case Reports

American Journal of Case Reports Anaplastic Transformation of Differentiated Papillary Thyroid Carcinoma Presenting as Cauda Equina Syndrome - Article abstract #932002

Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies

Frontiers Radionuclide 131I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer

Dosimetric Impacts of Source Migration, Radioisotope Type, and Decay with Permanent Implantable Collagen Tile Brachytherapy for Brain Tumors - Dilini S. Pinnaduwage, Shiv P. Srivastava, Xiangsheng Yan, Shyam Jani, David G. Brachman